Caribou Biosciences CRBU
NASDAQ CRBU
$1.22 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Caribou Biosciences (CRBU) Selling, General & Administrative (2020 - 2026)

Updated

Caribou Biosciences' Selling, General & Administrative came in at $7.9 million for Q2 2026, down 24.1% from $10.4 million a year earlier and down 2.1% from the prior quarter.

Analysis

Caribou Biosciences (CRBU) Selling, General & Administrative (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Caribou Biosciences reported Selling, General & Administrative of $33.74 million, down 16.6% year-over-year; for FY2025, it came in at $37.91 million, down 18.4% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of 21.9% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $46.46 million in FY2024 (+20.8%), $38.46 million in FY2023 (+1.2%), $38.02 million in FY2022 (+56.3%) and $24.32 million in FY2021 (+73.0%).
  • The Q2 2026 figure represents the lowest quarterly Selling, General & Administrative since Q4 2021.
  • Year-over-year, Selling, General & Administrative has declined for six consecutive quarters, with an average decline of 12.5% over the last eight quarters.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q1 2022 (growth of 108.7%), and the weakest in Q1 2025 (a decline of 33.5%).
  • Business Quant data shows CRBU's Selling, General & Administrative at $8.07 million (Q1 2026), $8.58 million (Q4 2025) and $9.2 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Caribou Biosciences 129.31 Mn -387.22 Mn - 7.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.90 Mn
Mar 31, 2026 8.07 Mn
Dec 31, 2025 8.58 Mn
Sep 30, 2025 9.20 Mn
Jun 30, 2025 10.40 Mn
Mar 31, 2025 9.74 Mn
Dec 31, 2024 10.49 Mn
Sep 30, 2024 9.84 Mn
Jun 30, 2024 11.49 Mn
Mar 31, 2024 14.64 Mn
Dec 31, 2023 9.72 Mn
Sep 30, 2023 9.71 Mn
Jun 30, 2023 10.12 Mn
Mar 31, 2023 8.91 Mn
Dec 31, 2022 8.53 Mn
Sep 30, 2022 9.85 Mn
Jun 30, 2022 10.04 Mn
Mar 31, 2022 9.59 Mn
Dec 31, 2021 7.85 Mn
Sep 30, 2021 6.76 Mn
API Access

Caribou Biosciences Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CRBU&period=max&api_key=YOUR_API_KEY